ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

FASEB: Focus on Research Funding, Not PR

June 14, 2013

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002